Related scientific articles (all)

Pregnancy after breast cancer: Are young patients willing to participate in clinical studies?

Authors : Pagani O, Ruggeri M, Manunta S, Saunders C, Peccatori F, Cardoso F, Kaufman B, Paluch-Shimon S, Gewefel H, Gallerani E, Abulkhair O, Pistilli B, Warner E, Saloustros E, Perey L, Zaman K, Rabaglio M, Gelber S, Gelber Rd, Godhirsch A, Korde L, Azim HA, Partridge AH
Year : 2015
Journal : Breast
Volume : 24(3)
Pages : 201-7

Cardiac assessment of early breast cancer patients 18years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy.

Authors : de Azambuja E, Ameye L, Diaz M, Vandenbossche S, Aftimos P, Hernández SB, Shih-Li C, Delhaye F, Focan C, Cornez N, Vindevoghel A, Beauduin M, Lemort M, Paesmans M, Suter T, Piccart-Gebhart M
Year : 2015
Journal : Eur J Cancer
Volume : 51
Pages : 2517-24

Tumour infiltrating lymphocytes (TILs) in breast cancer during pregnancy.

Authors : Azim HA, Vingiani A, Peccatori F, Viale G, Loi S, Pruneri G
Year : 2015
Journal : Breast
Volume : 24(3)
Pages : 290-3

Severe bilateral panuveitis during melanoma treatment by Dabrafenib and Trametinib.

Authors : Draganova D, Kerger J, Caspers L, Willermain F
Year : 2015
Journal : J Ophthalmic Inflamm Infect
Volume : 5
Pages : 17

High HER2 expression correlates with response to the combination of lapatinib and trastuzumab.

Authors : Scaltriti M, Nuciforo P, Bradbury I, Sperinde J, Agbor-Tarh D, Campbell C, Chenna A, Winslow J, Serra V, Parra JL, Prudkin L, Jimenez J, Aura C, Harbeck N, Pusztai L, Ellis C, Eidtmann H, Arribas J, Cortes J, de Azambuja E, Piccart-Gebhart M, Baselga J
Year : 2015
Journal : Clin Cancer Res
Volume : 21(3)
Pages : 569-76

Vulvar metastasis from bladder cancer.

Authors : Aoun F, El Rassy E, Kourie HR, Hawaux E, Van Velthoven R
Year : 2015
Journal : Case Rep Obstet Gynecol
Volume : 2015
Pages : 324634

Evaluating the pharmacokinetics and pharmacodynamics of everolimus for treating breast cancer.

Authors : Gombos A, Barthélémy P, Awada A
Year : 2015
Journal : Expert Opin Drug Metab Toxicol
Volume : 11(5)
Pages : 823-34.

Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.

Authors : Lambertini M, Ceppi M, Poggio F, Peccatori FA, Azim HA, Ugolini D, Pronzato P, Loibl S, Moore HC, Partridge AH, Bruzzi P, Del Mastro L
Year : 2015
Journal : Ann Oncol
Volume : 26
Pages : 2408-19

Has the time come for genomic tests to guide the use of adjuvant chemotherapy in node-positive breast cancer?

Authors : Azim HA
Year : 2015
Journal : Ann Oncol
Volume : 26(8)
Pages : 1521-3

New generations of targeted therapies fighting the resistance in solid tumors.

Authors : Barthélémy P, Aftimos P, Awada A
Year : 2015
Journal : Curr Opin Oncol
Volume : 27(3)
Pages : 243-9

What can be learned from our pediatric colleagues?

Authors : Klastersky J
Year : 2015
Journal : Curr Opin Oncol
Volume : 27
Pages : 283-4

Clinical Trials of Precision Medicine through Molecular Profiling: Focus on Breast Cancer.

Authors : Zardavas D, Piccart-Gebhart M
Year : 2015
Journal : Am Soc Clin Oncol Educ Book
Volume : 35
Pages : e183-90

Metabolic disorders associated with the use of targeted cancer therapies.

Authors : Kotecki N, Penel N, Awada A
Year : 2015
Journal : Curr Opin Oncol
Volume : 27(3)
Pages : 258-66

Immunology and breast cancer: toward a new way of understanding breast cancer and developing novel therapeutic strategies.

Authors : Gingras I, Azim HA Jr, Ignatiadis M, Sotiriou C
Year : 2015
Journal : Clin Adv Hematol Oncol
Volume : 13
Pages : 372-82

Tailoring therapies - improving the management of early breast cancer: St GallenInternational Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.

Authors : Coates AS, Winer EP, Goldhirsch A, Gelber Rd, Gnant M, Piccart-Gebhart M, Thürlimann B, Senn HJ
Year : 2015
Journal : Ann Oncol
Volume : 26(8)
Pages : 1533-46

Y90 radioembolization of colorectal cancer liver metastases: response assessment by contrast-enhanced computed tomography with or without PET-CT guidance.

Authors : Vouche M, Salem R, Miller FH, Lemort M, Vanderlinden B, De Becker D, Hendlisz A, Flamen P
Year : 2015
Journal : Clin Imaging
Volume : 39(3)
Pages : 454-62

Neoadjuvant Therapy for Breast Cancer.

Authors : Zardavas D, Piccart-Gebhart M
Year : 2015
Journal : Annu. Rev. Med.
Volume : 66
Pages : 31-48

Chemotherapy treatment patterns and neutropenia management in gastric cancer.

Authors : Kalinka-Warzocha E, Plazas JG, Mineur L, Salek T, Hendlisz A, Decosta L, Vogl FD, Passalacqua R
Year : 2015
Journal : Gastric Cancer
Volume : 18(2)
Pages : 360-7

A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck.

Authors : Machiels JP, Specenier P, Krauß J, Dietz A, Kaminsky MC, Lalami Y, Henke M, Keilholz U, Knecht R, Skartved NJ, Horak ID, Pamperin P, Braun S, Gauler TC
Year : 2015
Journal : Cancer Chemother Pharmacol
Volume : 76(1)
Pages : 13-20

Ambulatory Outpatient Management of patients with low risk febrile neutropaenia.

Authors : Cooksley T, Holland M, Klastersky J
Year : 2015
Journal : Acute Med
Volume : 14
Pages : 178-81